Saudi Arabia's Life Sciences Localisation Opportunity

Saudi Arabia’s life sciences localisation push is shifting from policy goals to execution, using Public Investment Fund (PIF)-backed platforms, government procurement, and foreign technology partnerships to build local healthcare capabilities. The agenda targets reducing import dependence, improving supply security, and supporting local manufacturing, while importing technology and eventually enabling regional exports. The article frames the effort not only as healthcare reform but also as industrial policy that can open paths for global companies beyond traditional selling and distribution. It says the National Unified Procurement Company (Nupco) is central, serving as a national procurement and logistics platform for pharmaceuticals, medical devices, and medical supplies. With public-sector demand influencing market access, pricing, and supply expectations, firms may need early procurement-focused strategy, local manufacturing or technology transfer structures, and revised legal planning for registration and tender requirements.